Scott Power
Stock Analyst at Morgans
(0.30)
# 4,532
Out of 5,070 analysts
236
Total ratings
34.9%
Success rate
-5.3%
Average return
Main Sectors:
Stocks Rated by Scott Power
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: BB1 BlinkLab Limited | Reiterated: Buy | $1.76 | $0.62 | +183.87% | 3 | Oct 1, 2026 | |
| ASX: IMR Imricor Medical Systems, Inc. | Reiterated: Buy | $2.90 | $1.35 | +115.61% | 16 | Oct 1, 2026 | |
| ASX: CGS Cogstate Limited | Reiterated: Buy | $4.07 | $3.58 | +13.69% | 1 | Sep 28, 2026 | |
| ASX: ARX Aroa Biosurgery Limited | Reiterated: Buy | $0.79 | $0.51 | +54.90% | 10 | Sep 10, 2026 | |
| ASX: IPD ImpediMed Limited | Downgraded: Hold | n/a | $0.004 | - | 33 | Aug 31, 2026 | |
| ASX: MX1 Micro-X Limited | Downgraded: Hold | $0.08 → $0.06 | $0.06 | +3.45% | 43 | Aug 31, 2026 | |
| ASX: SIG Sigma Healthcare Limited | Upgraded: Buy | $3.36 → $3.19 | $2.75 | +16.00% | 9 | Aug 28, 2026 | |
| ASX: PNV PolyNovo Limited | Reiterated: Buy | $1.48 → $1.21 | $0.90 | +34.44% | 13 | Aug 27, 2026 | |
| ASX: TTX Tetratherix Limited | Reiterated: Buy | $8.59 | $5.40 | +59.07% | 10 | Aug 21, 2026 | |
| NZE: EBO EBOS Group Limited | Reiterated: Buy | $28.25 → $28.26 | $21.10 | +33.96% | 23 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.85 → $0.05 | $0.05 | n/a | 8 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.43 → $5.32 | $3.03 | n/a | 18 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.55 | $0.22 | n/a | 18 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.09 → $1.20 | $0.71 | n/a | 19 | Feb 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2.33 → $1.89 | $4.68 | n/a | 12 | Dec 14, 2021 |
BlinkLab Limited
Oct 1, 2026
Reiterated: Buy
Price Target: $1.76
Current: $0.62
Upside: +183.87%
Imricor Medical Systems, Inc.
Oct 1, 2026
Reiterated: Buy
Price Target: $2.90
Current: $1.35
Upside: +115.61%
Cogstate Limited
Sep 28, 2026
Reiterated: Buy
Price Target: $4.07
Current: $3.58
Upside: +13.69%
Aroa Biosurgery Limited
Sep 10, 2026
Reiterated: Buy
Price Target: $0.79
Current: $0.51
Upside: +54.90%
ImpediMed Limited
Aug 31, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.004
Upside: -
Micro-X Limited
Aug 31, 2026
Downgraded: Hold
Price Target: $0.08 → $0.06
Current: $0.06
Upside: +3.45%
Sigma Healthcare Limited
Aug 28, 2026
Upgraded: Buy
Price Target: $3.36 → $3.19
Current: $2.75
Upside: +16.00%
PolyNovo Limited
Aug 27, 2026
Reiterated: Buy
Price Target: $1.48 → $1.21
Current: $0.90
Upside: +34.44%
Tetratherix Limited
Aug 21, 2026
Reiterated: Buy
Price Target: $8.59
Current: $5.40
Upside: +59.07%
EBOS Group Limited
Aug 20, 2026
Reiterated: Buy
Price Target: $28.25 → $28.26
Current: $21.10
Upside: +33.96%
Jan 8, 2024
Reiterated: Hold
Price Target: $0.85 → $0.05
Current: $0.05
Upside: n/a
Aug 23, 2023
Reiterated: Buy
Price Target: $5.43 → $5.32
Current: $3.03
Upside: n/a
Feb 28, 2022
Reiterated: Buy
Price Target: $1.55
Current: $0.22
Upside: n/a
Feb 18, 2022
Reiterated: Buy
Price Target: $1.09 → $1.20
Current: $0.71
Upside: n/a
Dec 14, 2021
Downgraded: Hold
Price Target: $2.33 → $1.89
Current: $4.68
Upside: n/a